Prognostic value of cardiac conduction delays in light-chain (AL) amyloidosis Among the different types cardiac amyloidoses, light-chain (AL) amyloidosis has the worst prognostic outcome. The mechanism of death is usually sudden cardiac death, due to tachyarrythmias, bradyarrythmias and/or electromechanical dissociation. To evaluate the possible association between these arrhythmic events and conduction delays detectable on a standard 12 lead ECG, prevalence and prognostic impact of conduction disturbances were assessed in 337 consecutive AL patients at the time of diagnosis; median follow up was 402 days. The prevalence of conduction delays was significantly higher in patients with cardiac AL amyloidosis than in patients without cardiac involvement (41% vs 24% respectively, p<0.05). Analysis of different morphologic, diastolic and systolic parameters (interventricular septum thickness, Doppler E/E’ ratio and mitral annulus longitudinal excursion or MAPSE) showed a worse echocardiographic presentation in cardiac AL patients with conduction delays. Furthermore, prognosis was markedly worse in patients with cardiac AL amyloidosis and intraventricular conduction delays.

Valore prognostico della presenza di disturbi della conduzione cardiaca nei pazienti affetti da amiloidosi AL

BOLDRINI, MICHELE;SALINARO, FRANCESCO;MUSSINELLI, ROBERTA;ALOGNA, ALESSIO;PALLADINI, GIOVANNI;MUSCA, FRANCESCO;MERLINI, GIAMPAOLO;PERLINI, STEFANO
2012-01-01

Abstract

Prognostic value of cardiac conduction delays in light-chain (AL) amyloidosis Among the different types cardiac amyloidoses, light-chain (AL) amyloidosis has the worst prognostic outcome. The mechanism of death is usually sudden cardiac death, due to tachyarrythmias, bradyarrythmias and/or electromechanical dissociation. To evaluate the possible association between these arrhythmic events and conduction delays detectable on a standard 12 lead ECG, prevalence and prognostic impact of conduction disturbances were assessed in 337 consecutive AL patients at the time of diagnosis; median follow up was 402 days. The prevalence of conduction delays was significantly higher in patients with cardiac AL amyloidosis than in patients without cardiac involvement (41% vs 24% respectively, p<0.05). Analysis of different morphologic, diastolic and systolic parameters (interventricular septum thickness, Doppler E/E’ ratio and mitral annulus longitudinal excursion or MAPSE) showed a worse echocardiographic presentation in cardiac AL patients with conduction delays. Furthermore, prognosis was markedly worse in patients with cardiac AL amyloidosis and intraventricular conduction delays.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/579669
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact